Earnings Preview: Sepracor Seeking Alpha, NY - 1 hour ago ... $308M vs. consensus of $292M. Positive catalysts this quarter could come from sales growth in Brovana, a COPD treatment, as well as Omnaris and Alvesco. ... |
Tips for Cold and Flu Season MarketWatch (press release) - 2 hours ago ... asthma or COPD, people who live in nursing homes and long term care facilities, and for people who live with or care for those who are at high risk. 2. ... |
Tips for Cold and Flu Season MarketWatch (press release) - 2 hours ago ... asthma or COPD, people who live in nursing homes and long term care facilities, and for people who live with or care for those who are at high risk. 2. ... |
MPCA issues advisory on air quality Post-Bulletin, MN - 5 hours ago We've got cold, dry air and those fine particles," said Yawn, who is also co-chair of the United States COPD Coalition and research director at Olmsted ... |
MPCA issues advisory on air quality Post-Bulletin, MN - 5 hours ago We've got cold, dry air and those fine particles," said Yawn, who is also co-chair of the United States COPD Coalition and research director at Olmsted ... |
MPCA issues advisory on air quality Post-Bulletin, MN - 5 hours ago We've got cold, dry air and those fine particles," said Yawn, who is also co-chair of the United States COPD Coalition and research director at Olmsted ... |
Vectura sees strong H1 cash position guardian.co.uk, UK - 7 hours ago It pointed out that Novartis had confirmed 2011 as the year that it will request regulatory approval for its COPD drugs NVA237 and QVA149. ... Vectura sees strong H1 cash position Reuters STOCKS NEWS EUROPE-Vectura rises on update; Teathers says "buy" Reuters UK all 8 news articles |
Vectura sees strong H1 cash position guardian.co.uk, UK - 7 hours ago It pointed out that Novartis had confirmed 2011 as the year that it will request regulatory approval for its COPD drugs NVA237 and QVA149. ... Vectura sees strong H1 cash position Reuters STOCKS NEWS EUROPE-Vectura rises on update; Teathers says "buy" Reuters UK all 8 news articles |
Vectura sees strong H1 cash position guardian.co.uk, UK - 7 hours ago It pointed out that Novartis had confirmed 2011 as the year that it will request regulatory approval for its COPD drugs NVA237 and QVA149. ... Vectura sees strong H1 cash position Reuters STOCKS NEWS EUROPE-Vectura rises on update; Teathers says "buy" Reuters UK all 8 news articles |
Vectura sees strong H1 cash position guardian.co.uk, UK - 7 hours ago It pointed out that Novartis had confirmed 2011 as the year that it will request regulatory approval for its COPD drugs NVA237 and QVA149. ... Vectura sees strong H1 cash position Reuters STOCKS NEWS EUROPE-Vectura rises on update; Teathers says "buy" Reuters UK all 8 news articles |